Loading clinical trials...
Loading clinical trials...
The purpose of the study is to see if a medication (Recombinant Coagulation Factor VIIa or NovoSeven), normally used to stop bleeding in persons with a bleeding disorder, will lower the amount of bloo...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
United States Army Institute of Surgical Research
NCT06162052 · Burns
NCT06596434 · Burns, Second Degree Burn, and more
NCT06814717 · Thermal Burns
NCT07312513 · Diabetic Ulcers, Arterial Ulcers, and more
NCT07277166 · Burns, Gait Dysfunction, and more
United States Army Institute of Surgical Research
Fort Sam Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions